Verified AI news
Stories without a progress claim: acquisitions, partnerships, hires, funding rounds, regulatory news. Facts confirmed against primary sources. The default rating — about 60% of stories.
- June 29, 2026·Fintech Global
Fenergo hires Finastra CRO to lead global revenue expansion
Lekshmi Nair joins Fenergo as chief revenue officer, overseeing go-to-market strategy for the AI-powered client lifecycle management vendor serving financial institutions.
- June 29, 2026·Fintech Global
Your AI compliance gap is wider than your governance framework
Theta Lake CPO Dan Nadir on why firms struggle with AI governance even as adoption accelerates. What auditable AI interaction trails must include and how compliance teams should rethink accountability.
- June 29, 2026·Fintech Global
UK banks have 18 months to map third-party risks under PS26/2
The FCA, PRA, and Bank of England are enforcing PS26/2 from March 2027, requiring firms to report operational incidents and maintain registers of material suppliers. Compliance means auditable processes, not checkbox exercises.
- June 29, 2026·Fintech Global
Compliance teams ditch spreadsheets for unified EDD software
Regulators now demand proof of enhanced due diligence: documentation, decision trails, and continuous monitoring. KYC360 integrates source-of-wealth verification, adverse media screening, and UBO identification into one auditable platform to cut onboarding time by up to 80%.
- June 29, 2026·Fintech Global
Quantifind Lands $200M to Scale AI-Native Financial Crime Detection
Summit Partners leads $200M growth round for risk intelligence platform serving six of the world's top 10 Tier 1 banks. The capital funds expansion of Graphyte, an agentic middleware system designed to cut false positive rates in AML and KYC screening.
- June 29, 2026·American Banker
Banks face 500% token bill spike as AI pricing shifts
Royal Bank of Canada's token costs jumped 500% in one year as AI providers switched from subscriptions to per-unit billing. Here's how banks are cutting costs without ditching AI.
- June 29, 2026·American Banker
AI's true cost emerges as vendors end subsidies, banks hunt cheaper options
Tech companies are switching from flat-rate AI pricing to per-token charges, forcing banks to confront real costs that far exceed what they budgeted. Some have burned through a year's spend in months.
- June 29, 2026·American Banker
Stop scripting your salespeople into silence
Bank trainer Dave Martin revisits a 20-year-old principle: overly detailed sales scripts kill employee judgment. Clear roles and permission to think work better.
- June 29, 2026·Adweek
Cannes Lions: Five Ad Giants Deploy Agent Infrastructure
Nvidia, Yahoo, Palantir, Pinterest, and Fox unveiled AI agent frameworks at Cannes Lions 2026 that let agents coordinate to handle ad creation, buying, and targeting. What this means for your marketing stack.
- June 29, 2026·Adweek
Omnicom cuts 10,000 jobs after IPG merger closes
Omnicom CEO John Wren closed the $13B acquisition of Interpublic Group in December, eliminating iconic agency brands and slashing headcount. What comes next for the ad industry's largest consolidation.
- June 29, 2026·Adweek
Cannes Lions Shows AI's Shift From Hype to Creative Tool
Cannes Lions added its first AI Craft category, but award winners reveal AI is now support for human creativity, not the main event. What the shift means for ad teams.
- June 29, 2026·Crunchbase News
Q2 2026 sets billion-dollar startup exit record since 2021 peak
SpaceX's $2.1 trillion IPO and Cursor's $60B acquisition by SpaceX drove Q2's highest count of $1B+ exits in five years. What's changing about exit velocity.
- June 29, 2026·HR Dive
Small businesses overlook 3 employee management risks hiding in plain sight
HR Dive identifies three widespread assumptions about employee management that expose small businesses to hidden compliance and operational risk. Learn what they are and how to spot them.
- June 29, 2026·HR Dive
Compliance training must prove readiness, not just completion
HR leaders are shifting compliance programs away from seat-time metrics toward measurable workforce readiness. Here's what the standard actually requires.
- June 29, 2026·HR Executive
Volkswagen plans 100,000 layoffs and four plant closures
VW CEO Oliver Blume has presented plans to cut 15% of the global workforce and shutter German factories. The supervisory board meets July 9 to decide, but unions say they will fight the move.
- June 29, 2026·HR Executive
Your compensation data is stale. AI will scale that problem.
HR teams are layering AI onto outdated survey data and manual processes. Payscale research shows 53% worry AI will reduce human judgment; 44% fear bias. Here's what actually needs to change first.
- June 29, 2026·HR Executive
86% of remote tech jobs pay $7,700 less annually than office roles
JobLeads analyzed 42 standardized tech positions and found a 6% pay cut for remote work—except at the executive level, where VPs earn $39K more remotely. What HR leaders should know about comp equity.
- June 29, 2026·HR Executive
49% of Americans can't afford healthcare—lowest rate since 2021
West Health–Gallup data shows fewer than half of U.S. adults can consistently pay for care and medications. Racial and income disparities are widening sharply.
- June 29, 2026·HR Executive
JPMorgan exec exits after viral trash video—what HR can't do
A JPMorgan Chase director left the company after a video of her dumping trash went viral. The incident exposes a legal trap: employers who fire workers for off-duty conduct may violate New York's broad leisure-activity protections.
- June 29, 2026·HR Morning
Your team needs watercooler breaks. Here's why remote work made it harder.
Informal workplace connections drive engagement, retention, and safety — but hybrid teams lose them by default. Four workplace staples show how to rebuild them.
- June 29, 2026·Reuters Legal
Three major Trump rulings due as Supreme Court's term ends
The Supreme Court will issue three significant decisions affecting Trump before its term concludes. Legal experts expect rulings on major constitutional and criminal matters in coming weeks.
- June 29, 2026·Reuters Legal
Alaska judge restores Dan Sullivan to Senate ballot in write-in ruling
An Alaska state court ordered election officials to place write-in candidate Dan Sullivan back on the US Senate ballot after he was initially removed. The ruling affects November's Senate race and clarifies state write-in eligibility rules.
- June 29, 2026·Reuters Legal
Australia empowers regulator to fine Big Tech over under-16 ban
Australia's communications regulator gains enforcement authority to pursue social media platforms that fail to comply with a new under-16 user ban. The shift gives the ACMA direct power to issue penalties and court orders.
- June 29, 2026·Reuters Legal
Williams eyes $5.5B Momentum Midstream acquisition
Williams Companies is in talks to acquire Momentum Midstream for $5.5 billion, according to Bloomberg. The deal would expand Williams' natural gas and CO2 pipeline network.
- June 29, 2026·Reuters Legal
Stock rally's margin debt gets pricier as Fed rates stay high
Borrowed money fueling the US stock market surge is costing investors more. Here's why margin rates matter to your portfolio and what's changing.
- June 29, 2026·LegalTechnology
Law Firms Doubling AI Use Without a Strategy—Here's Why That Fails
40% of legal professional services now use AI, but most firms lack a defined 'why' for adoption. Sophie Tversky explains why top-down mandates backfire and how to build AI strategy that sticks.
- June 29, 2026·Artificial Lawyer
Law firms build their own AI instead of renting from OpenAI
Thomson Reuters, Kirkland & Ellis, and Harvey are training custom models on proprietary legal data to escape dependence on US-based AI vendors. Why control over AI infrastructure is becoming a competitive advantage.
- June 29, 2026·EU Commission / AI Act
EMA Backs Hopledo for Parkinson's Treatment
European Medicines Agency recommends approval of Hopledo, marking a regulatory milestone for AI-assisted drug development. The decision reflects growing confidence in computational methods for neurological disease.
- June 29, 2026·EU Commission / AI Act
Taggd Expands Hiring Platform After EU Acquisition Deal
Recruitment platform Taggd closes European acquisition. Company sees AI and full-stack hiring as the next hiring frontier. What this means for your recruitment stack.
- June 29, 2026·EU Commission / AI Act
Blanchett launches AI consent tool at European Parliament
Actor Cate Blanchett unveiled a new tool designed to help individuals manage consent for AI systems at the EU Parliament. The move reflects growing concern over AI data practices and user control under the EU AI Act.
- June 29, 2026·EU Commission / AI Act
EU AI Act compliance now live: what finance firms must do
The EU AI Act enters enforcement phase for financial services. Cyprus-based firms have early advantage in meeting new transparency and risk rules. What the compliance checklist covers.
- June 29, 2026·EU Commission / AI Act
Stellar Cyber ranks Top 3 XDR platform in EMA review
EMA names Stellar Cyber a top-three Extended Detection and Response solution, citing its AI-native SecOps platform. What separates it from competitors.
- June 29, 2026·UK Regulators (AI)
FCA stops waiting for AI law — starts enforcing now
The UK Financial Conduct Authority is setting its own AI standards rather than waiting for legislation. Here's what firms need to do to stay compliant.
- June 29, 2026·UK Regulators (AI)
UK FCA puts 'test and scale' at heart of financial AI push
Britain's financial regulator is making controlled testing and gradual deployment the core of its AI oversight approach. Here's what firms need to know about compliance.
- June 29, 2026·UK Regulators (AI)
FCA flags three tech trends firms must monitor in 2026
The UK's Financial Conduct Authority published its Emerging Technology Horizon Scan 2026, identifying three technology shifts regulators expect to reshape financial services compliance. Here's what's on the watchlist.
- June 29, 2026·UK Regulators (AI)
FCA sets AI governance rules for UK financial firms
The UK Financial Conduct Authority has published expectations on how banks and insurers should govern AI systems. Firms must document risk controls and audit decisions before deployment.
- June 29, 2026·PR Newswire (AI Health)
Rocket Lab to buy Iridium satellite operator in $US800M deal
Rocket Lab announced plans to acquire Iridium Communications for $800 million, combining launch services with a deployed constellation of 66 satellites in orbit. The all-cash deal aims to create a vertically integrated space business.
- June 29, 2026·PharmaTimes
FDA approves Lumvoa for thyroid eye disease in active and chronic forms
Viridian Therapeutics wins first FDA approval for Lumvoa, the first TED treatment with labeling for both active and chronic disease. Clinical data showed proptosis reduction in three weeks.
- June 29, 2026·Pharmaceutical Technology
Lilly's pirtobrutinib wins EU backing for chronic lymphocytic leukaemia
EMA committee recommended Jaypirca for CLL across all treatment lines, with European Commission decision expected in one to two months. US FDA ruling anticipated in H2 2026.
- June 29, 2026·Pharmaceutical Technology
FDA Clears NASP Safety and Efficacy But Halts Approval on Manufacturing
Sobi's gout therapy passed clinical review but faces manufacturing deficiency questions. The FDA wants detail on biological component controls and contract facility operations before resubmission.
- June 29, 2026·Pharmaceutical Technology
Biogen cuts Apellis pipeline, suspends two rare disease trials post-$5.6B buyout
Three months after acquiring Apellis for $5.6 billion, Biogen is pausing or ending most legacy research programs and trimming R&D staff. The move signals a focus on commercializing pegcetacoplan's approved indications.
- June 29, 2026·Labiotech.eu
VIB's 40 spinoffs raised €2B while EU grants fund only 2% of proposals
Belgium's biotech institute fuels startups amid a European funding crisis. VIB has spun out companies like Orionis (Novartis deal: $1.4B) and Rainbow Crops (Gates grant: $7M), but its director warns only 2% of grant submissions succeed across Europe.
- June 29, 2026·GEN
SK Biopharm, Insilico Strike $2.5B AI Drug Deal for Brain Disorders
South Korean pharma giant SK partners with AI drug discovery firm Insilico to develop neuroimmune therapies. SK handles late-stage trials and U.S. sales; Insilico handles AI-powered design and early development.
- June 29, 2026·ET HealthWorld
India cuts medical device licensing timelines by 25 days
The health ministry proposed faster approvals for Class B, C, and D devices. Class B timelines drop from 140 to 115 days; high-risk devices from 105 to 90 days.
- June 29, 2026·ET HealthWorld
India's nutraceutical market to nearly double to $57B by 2030
India's $30B nutraceutical sector is projected to reach $57B by 2030, growing at 10.5% annually as consumers shift toward preventive health. Here's what's driving the expansion.
- June 29, 2026·ET HealthWorld
India launches risk-stratified child healthcare for infants under 3
India's new Samagra Shishu Bal Swasthya Karyakram assigns newborns up to 9 home visits in 42 days, at-risk children up to 8 visits through age 3. Here's what integrates into the program.
- June 29, 2026·ET HealthWorld
India Adds Newborns to Anaemia Program, Expands Digital Tracking
India's health ministry overhauled its anaemia control framework to include low birth weight babies for the first time and added digital portal tracking. The revamped program shifts from iron supplements alone to testing, treatment, nutrition, and follow-up.
- June 29, 2026·ET HealthWorld
India targets maternal mortality below 70 per 100k by 2030 with SUMAN Roadmap
India's health ministry launches SUMAN Roadmap 2030 to reduce maternal and infant deaths through targeted interventions in 130 districts and 13 high-focus states. The framework integrates pre-pregnancy through postnatal care.
- June 29, 2026·ETHealth
Doctor-Built AI Platform Verifies Health Advice Against Medical Literature
HIVE, developed by a Chennai epidemiologist, cross-checks AI recommendations against patient records, clinical guidelines, and medical literature before presenting them to doctors and frontline workers.
- June 29, 2026·BioPharma Dive
10 clinical trials to watch in 2H 2026: lung cancer, Alzheimer's, autoimmune updates
BioPharma Dive flags 10 key trials expected in the second half of 2026, with anticipated results in lung cancer, Alzheimer's, and autoimmune conditions. Here's what's on the calendar and why investors and patient advocates are watching closely.